大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/15 | 3,980 | 3,987 | 3,950 | 3,973 | +24 | +0.6% | 1,539,300 |
2023/03/14 | 3,955 | 3,964 | 3,891 | 3,949 | -60 | -1.5% | 2,038,700 |
2023/03/13 | 4,002 | 4,017 | 3,977 | 4,009 | -34 | -0.8% | 1,804,900 |
2023/03/10 | 4,044 | 4,068 | 4,032 | 4,043 | -35 | -0.9% | 2,416,400 |
2023/03/09 | 4,088 | 4,090 | 4,055 | 4,078 | +3 | +0.1% | 1,768,600 |
2023/03/08 | 4,060 | 4,082 | 4,042 | 4,075 | +37 | +0.9% | 2,542,600 |
2023/03/07 | 3,949 | 4,042 | 3,946 | 4,038 | +78 | +2% | 4,211,100 |
2023/03/06 | 3,979 | 3,983 | 3,928 | 3,960 | +17 | +0.4% | 4,553,900 |
2023/03/03 | 3,838 | 3,949 | 3,827 | 3,943 | -175 | -4.2% | 10,278,600 |
2023/03/02 | 4,143 | 4,155 | 4,102 | 4,118 | -4 | -0.1% | 892,000 |
2023/03/01 | 4,148 | 4,150 | 4,091 | 4,122 | -12 | -0.3% | 919,500 |
2023/02/28 | 4,131 | 4,147 | 4,119 | 4,134 | -12 | -0.3% | 1,644,300 |
2023/02/27 | 4,137 | 4,150 | 4,115 | 4,146 | +1 | ±0% | 849,700 |
2023/02/24 | 4,121 | 4,147 | 4,067 | 4,145 | +15 | +0.4% | 1,342,600 |
2023/02/22 | 4,162 | 4,177 | 4,098 | 4,130 | -39 | -0.9% | 1,495,800 |
2023/02/21 | 4,150 | 4,169 | 4,129 | 4,169 | +5 | +0.1% | 941,600 |
2023/02/20 | 4,209 | 4,219 | 4,159 | 4,164 | -11 | -0.3% | 1,017,300 |
2023/02/17 | 4,179 | 4,197 | 4,162 | 4,175 | -32 | -0.8% | 1,455,600 |
2023/02/16 | 4,200 | 4,216 | 4,167 | 4,207 | +9 | +0.2% | 1,080,800 |
2023/02/15 | 4,197 | 4,294 | 4,188 | 4,198 | +11 | +0.3% | 1,362,500 |
2023/02/14 | 4,153 | 4,255 | 4,130 | 4,187 | +87 | +2.1% | 1,373,600 |
2023/02/13 | 4,121 | 4,134 | 4,090 | 4,100 | -37 | -0.9% | 637,400 |
2023/02/10 | 4,174 | 4,178 | 4,112 | 4,137 | +5 | +0.1% | 1,010,500 |
2023/02/09 | 4,117 | 4,142 | 4,105 | 4,132 | ±0 | ±0% | 625,700 |
2023/02/08 | 4,121 | 4,155 | 4,108 | 4,132 | +44 | +1.1% | 718,100 |
2023/02/07 | 4,107 | 4,137 | 4,080 | 4,088 | -32 | -0.8% | 763,600 |
2023/02/06 | 4,130 | 4,137 | 4,106 | 4,120 | +33 | +0.8% | 765,500 |
2023/02/03 | 4,101 | 4,134 | 4,084 | 4,087 | -28 | -0.7% | 788,600 |
2023/02/02 | 4,130 | 4,134 | 4,107 | 4,115 | -38 | -0.9% | 544,900 |
2023/02/01 | 4,188 | 4,193 | 4,140 | 4,153 | -5 | -0.1% | 687,800 |
2023/01/31 | 4,190 | 4,200 | 4,154 | 4,158 | -12 | -0.3% | 879,000 |
2023/01/30 | 4,159 | 4,183 | 4,152 | 4,170 | -12 | -0.3% | 687,200 |
2023/01/27 | 4,218 | 4,218 | 4,169 | 4,182 | -24 | -0.6% | 657,000 |
2023/01/26 | 4,242 | 4,256 | 4,201 | 4,206 | -20 | -0.5% | 665,300 |
2023/01/25 | 4,235 | 4,257 | 4,220 | 4,226 | +6 | +0.1% | 886,100 |
2023/01/24 | 4,189 | 4,237 | 4,175 | 4,220 | +55 | +1.3% | 1,038,900 |
2023/01/23 | 4,184 | 4,192 | 4,154 | 4,165 | +7 | +0.2% | 810,600 |
2023/01/20 | 4,155 | 4,158 | 4,128 | 4,158 | +28 | +0.7% | 957,700 |
2023/01/19 | 4,133 | 4,153 | 4,115 | 4,130 | -44 | -1.1% | 821,500 |
2023/01/18 | 4,088 | 4,177 | 4,060 | 4,174 | +96 | +2.4% | 1,389,600 |
2023/01/17 | 4,063 | 4,082 | 4,034 | 4,078 | +30 | +0.7% | 906,400 |
2023/01/16 | 4,015 | 4,064 | 4,011 | 4,048 | -9 | -0.2% | 757,900 |
2023/01/13 | 4,050 | 4,073 | 4,023 | 4,057 | -29 | -0.7% | 1,315,100 |
2023/01/12 | 4,091 | 4,104 | 4,068 | 4,086 | -1 | ±0% | 801,300 |
2023/01/11 | 4,057 | 4,103 | 4,056 | 4,087 | +45 | +1.1% | 1,024,200 |
2023/01/10 | 4,084 | 4,101 | 4,034 | 4,042 | -61 | -1.5% | 1,165,400 |
2023/01/06 | 4,099 | 4,128 | 4,089 | 4,103 | +3 | +0.1% | 783,000 |
2023/01/05 | 4,144 | 4,153 | 4,090 | 4,100 | -29 | -0.7% | 902,900 |
2023/01/04 | 4,251 | 4,257 | 4,129 | 4,129 | -176 | -4.1% | 970,200 |
2022/12/30 | 4,322 | 4,347 | 4,299 | 4,305 | -28 | -0.6% | 736,200 |
601~
650
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 781,500円 | +2.2% | +28.0% | 1.79% | 12.51倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 439,900円 | -1.1% | +75.3% | 4.55% | 30.47倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 356,300円 | +6.0% | +4.0% | 2.19% | 21.99倍 | 4.06倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,200円 | +0.9% | +380.2% | 4.81% | 22.34倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 253,400円 | +20.9% | +10.6% | 2.60% | 11.98倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム